Cyclobutanetetrone, tetrakis(phenylhydrazone)(65626-65-5)
- Name: Cyclobutanetetrone, tetrakis(phenylhydrazone)
- Synonyms:
- Molecular Formula:C28H24N8
- Molecular Weight:472.552
- CAS Registry Number:65626-65-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.65626-65-5 Cyclobutanetetrone, tetrakis(phenylhydrazone)
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 65625-83-4/2H-1-Benzopyran-2-one, 4-(4-morpholinyl)-
- 656260-39-8/2-Propanone, compd. with 3-[[(triphenylstannyl)oxy]carbonyl]-2-[(triphenylstannyl)thio]pyridine (1:1)
- 65626-25-7/1-Propanamine, 3-[(2,4-diethyloctyl)oxy]-
- 65626-26-8/L-Aspartic acid, N-[3-[(2-ethylhexyl)oxy]propyl]-, diethyl ester
- 65626-27-9/L-Aspartic acid, N-[3-(decyloxy)propyl]-, diethyl ester
- 65626-28-0/L-Aspartic acid, N-[3-[(2,4-diethyloctyl)oxy]propyl]-, diethyl ester
- 65626-29-1/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, 1,4-diethyl ester
- 65626-30-4/L-Aspartic acid, N-(3-carboxy-5,7-diethyl-1-oxoundecyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, 1,4-diethyl ester
- 65626-31-5/L-Aspartic acid, N-(3-carboxy-1-oxopropyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, 1,4-diethyl ester
- 65626-32-6/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-(decyloxy)propyl]-, 1,4-diethyl ester
- 65626-33-7/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-[(2,4-diethyloctyl)oxy]propyl]-, 1,4-diethyl ester
- 65626-34-8/L-Aspartic acid, N-(3-carboxy-1-oxo-2-propenyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, 1,4-diethyl ester
- 65626-35-9/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, trisodium salt
- 65626-36-0/L-Aspartic acid, N-(3-carboxy-1-oxopropyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, trisodium salt
- 65626-37-1/L-Aspartic acid, N-(3-carboxy-5,7-diethyl-1-oxoundecyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, trisodium salt
- 65626-38-2/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-(decyloxy)propyl]-, trisodium salt
- 65626-39-3/L-Aspartic acid, N-(3-carboxy-5-ethyl-1-oxononyl)-N-[3-[(2,4-diethyloctyl)oxy]propyl]-, trisodium salt
- 65626-40-6/L-Aspartic acid, N-(3-carboxy-1-oxo-2-propenyl)-N-[3-[(2-ethylhexyl)oxy]propyl]-, trisodium salt
- 65626-64-4/Cyclobutanetetrone, tetrahydrazone
- 65626-65-5/Cyclobutanetetrone, tetrakis(phenylhydrazone)
- 65626-66-6/Cyclobutanetetrone, tetrakis(methylhydrazone)
- 65626-68-8/2,4(1H,3H)-Quinazolinedithione, 5,6,7,8-tetrahydro-3-(2-hydroxyethyl)-
- 65626-69-9/2,4(1H,3H)-Quinazolinedithione, 5,6,7,8-tetrahydro-3-(3-hydroxypropyl)-
- 65626-70-2/2,4(1H,3H)-Quinazolinedithione, 5,6,7,8-tetrahydro-3-(2-propenyl)-
- 65626-71-3/5H-Thiazolo[3,2-c]quinazoline-5-thione, 2,3,7,8,9,10-hexahydro-
- 65626-72-4/5H-Thiazolo[3,2-c]quinazoline-5-thione, 2,3,7,8,9,10-hexahydro-2-methyl-
- 65626-73-5/2H,6H-[1,3]Thiazino[3,2-c]quinazoline-6-thione, 3,4,8,9,10,11-hexahydro-, monohydrochloride
- 65626-74-6/5H-Thiazolo[2,3-b]quinazoline-5-thione, 2,3,6,7,8,9-hexahydro-
- 65626-75-7/5H-Thiazolo[2,3-b]quinazoline-5-thione, 2,3,6,7,8,9-hexahydro-2-methyl-
- 65626-76-8/2H,6H-[1,3]Thiazino[2,3-b]quinazoline-6-thione, 3,4,7,8,9,10-hexahydro-